Innate Pharma SA announced three abstracts including Innate’s product candidates have been accepted for the American Society for Clinical Oncology 2023 Annual Meeting, taking place June 2-6, 2023 in Chicago, IL. One abstract for SAR’579, currently developed by Sanofi, has been selected for oral presentation.
